China Pharma to issue 12.6 million shares for $8.82 million patent transfer
On February 5, 2026, subsidiary Hainan Helpson Medical & Biotechnology entered a Technology Transfer Agreement with Xiaoyun Chen to acquire ownership of an invention patent for a Topiroxostat nanoemulsion. The transfer price is $8.82 million, paid in restricted common stock at $0.70 per share, and the closing is expected by February 20, 2026. The share issuance will add 12,600,000 shares to the company's common stock outstanding.
Key points
- Transfer price of $8.82 million, paid in common stock at $0.70 per share
- Company is to issue 12,600,000 restricted shares of common stock
- Closing expected by February 20, 2026
- Shares are unregistered and issued under Regulation S to a non-U.S. person
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 10, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.